Ruth Devenyns

Ruth Devenyns is the current CEO of Precirix and has held various other positions in the past including investment director, CFO, and senior advisor. Ruth has a wide range of experience in areas such as investing, strategy consulting, and operational management. Ruth began their career in 2001 as an investment director for KBC Private Equity and then became the CEO of Precirix in 2008. In 2011, they became an independent director for MDxHealth and held that position until 2018. Ruth has also been a director for FlandersBio since 2008 and currently serves on its finance committee.

Ruth Devenyns has a Master's degree in Applied Economics from Ghent University.

Some individuals on their team include Tony Lahoutte - CSO, Dimitrios Mantzilas - CTO, and Niva Almaula - CBO.